In addition, Akum also said that the Zambian government shall purchase medicines from the JV having a minimum aggregate value of $50 million over 2 years in 2026 and 2027, i.e., USD 25 million annually, which will be manufactured and supplied from Akum’s and/or its subsidiaries’ facilities in India.